OK advanced warning, I'm not being political, but
Post# of 148187
With the obvious timing of this morning's Pfizer vaccine announcement and now EUA for Lilly's mab, one cannot discount the fact that they perfectly coincided with election results. That is, a concerted effort to withhold good news until Biden gets elected.
This may have led to Cytodyn's receiving the "don't bother filing for EUA for m/m" response from the FDA. This makes me very optimistic now that leronlimab will get EUA at 75% interim review.